Delivery Order SPE2DB22D3016-SPE2DB24FAWX2

Award Date 5/30/24
Potential Completion Date 5/31/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,293.93 firm fixed price delivery order is for the supply of Phenobarbital 130 mg/ml vials, a medication used to treat certain types of seizures. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of PHENOBARBITAL 65 MG/ML VIALML to the U.S. Department of Defense (DoD) and its agencies. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $1,223.55. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award...
This federal contract award, valued at $1,551.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Phenobarbital 130 mg/ml vials, a medication commonly used in the treatment of seizure disorders. The contract has an ultimate completion date of March 6, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $2,885.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Phenobarbital 130 mg/ml vials, a medication commonly used for the treatment of seizure disorders. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of Phenobarbital 65 mg/ml vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $1,625.60 and an ultimate completion date of January 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,785.13, is for the delivery of Phenobarbital 65mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 9, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, with an ID of SPE2DB22D2206|SPE2DB25FFL15, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is for the delivery of 4567155758 - Phenobarbital 130 mg/mL vials, with a ceiling value of $2,395.34 and a completion date of February 5, 2025. This is a Firm Fixed Price Delivery Order contract, and there was no set-aside used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award, valued at $1,922.57, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the procurement of PHENOBARBITAL SODIUM medical supplies, with an ultimate completion date of September 5, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price valued at $1,096.28 and a period of performance through February 5, 2025. The contract is for the supply of PHENOBARBITAL 130 MG/ML VIAL, which is a medication used for treatment of various medical conditions. This appears to be a stand-alone contract award, as there is no mention of it being...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,027.94 Firm Fixed Price Delivery Order (SPE2DX15D1022|SPE2DX23FVGVL) is for the supply of Phenobarbital 130 mg/ml vials. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAWX2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of 130 mg/mL vials of the drug Phenobarbital. The contract has a ceiling value of $3,785.92 and is a Delivery Order (DO) under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market.

Generated 8/29/24, 9:38 AM